Checkpoint investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates adequacy of price and process in proposed sale of checkpoint therapeutics, inc. - ckpt

New york & new orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of checkpoint therapeutics, inc. (nasdaqcm: ckpt) to sun pharmaceutical industries limited. under the terms of the proposed transaction, shareholders of checkpoint will receive $4.10 per share and a contingent value right for up to $0.70 per share on achievement of a milestone. ksf is seeking to determ.
GM Ratings Summary
GM Quant Ranking